Article

Fft.com on 2017-08-02 10:01

Novartis faces vexing decisions over asset sales

Lionel Barber

Related news

FShell faces fresh hurdle in asset sales goal ft.com
South East Asia , China
FValeant raises $2.1bn through asset sales ft.com
South East Asia , China
FGE boss unveils dividend cut and $20bn asset sales ft.com
South East Asia , China
FNovartis faces possible S Korea sales ban ft.com
Seoul , South Korea
FNovartis appoints chief to replace Jimenez ft.com
South East Asia , China
FOil & Gas: Japan deal complications put Shell asset sales goal at risk ft.com
South East Asia , China , Japan
FNovartis cancer drug moves step closer to approval ft.com
South East Asia , China
FNestlé and Novartis rethink role in Turkey ad campaign ft.com
South East Asia , China , Turkey
GSK sees drop in earnings after asset swap with Novartis The Findlay Courier
China , Switzerland
WGSK, Novartis wrap up $21B asset swap, form joint venture wraltechwire.com
China , Australia , Springs , Research Triangle Park
Novartis drug firm faces Turkey bribe probe thelocal.ch
China , Switzerland , Basel , Turkey
FNovartis faces 15-day suspension in Japan ft.com
China , Tokyo Prefecture , Switzerland , Basel , Japan
FBitcoin’s surge fuels fears of asset bubble ft.com
South East Asia , China
FUS asset managers consider performance fees ft.com
South East Asia , China
FAsset managers fine tune Brexit contingency plans ft.com
South East Asia , China
FFCA’s asset management review: six things to watch ft.com
South East Asia , China
FThere’s a new landlord in town: asset managers ft.com
South East Asia , China
FEuropean watchdog urged to probe asset manager fees ft.com
South East Asia , China , Europe
FLloyds helped HBOS fraudsters to buy asset cheaply ft.com
South East Asia , China